EMD Serono Research & Development Institute, Inc.
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
EMD Serono Research & Development Institute, Inc. is a clinical trial sponsor. It has 15 active clinical trials with 4,231 planned participants, across 15 therapeutic areas. Since 2021 it has completed 32 trials and stopped 25 early.
Trial track record · since 2021
Pipeline · 15 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about EMD Serono Research & Development Institute, Inc
EMD Serono Research & Development Institute, Inc is lead sponsor of 15 active clinical trials on ClinicalTrials.gov, with 4,231 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 32 trials and stopped 25 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with EMD Serono Research & Development Institute, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with EMD Serono Research & Development Institute, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.